{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T07:56:22Z","timestamp":1780386982483,"version":"3.54.1"},"reference-count":92,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T00:00:00Z","timestamp":1723161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The National High-Level Hospital Clinical Research Funding","award":["2022-PUMCH-A-178"],"award-info":[{"award-number":["2022-PUMCH-A-178"]}]},{"name":"The National High-Level Hospital Clinical Research Funding","award":["L232016"],"award-info":[{"award-number":["L232016"]}]},{"name":"The National High-Level Hospital Clinical Research Funding","award":["2022-I2M-1-003"],"award-info":[{"award-number":["2022-I2M-1-003"]}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["2022-PUMCH-A-178"],"award-info":[{"award-number":["2022-PUMCH-A-178"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["L232016"],"award-info":[{"award-number":["L232016"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["2022-I2M-1-003"],"award-info":[{"award-number":["2022-I2M-1-003"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["2022-PUMCH-A-178"],"award-info":[{"award-number":["2022-PUMCH-A-178"]}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["L232016"],"award-info":[{"award-number":["L232016"]}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["2022-I2M-1-003"],"award-info":[{"award-number":["2022-I2M-1-003"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Breath analysis, despite being an overlooked biomatrix, has a rich history in disease diagnosis. However, volatile organic compounds (VOCs) have yet to establish themselves as clinically validated biomarkers for specific diseases. As focusing solely on late-stage or malignant disease biomarkers may have limited relevance in clinical practice, the objective of this review is to explore the potential of VOC breath tests for the diagnosis of non-cancer diseases: (1) Precancerous conditions like gastro-esophageal reflux disease (GERD) and Barrett\u2019s esophagus (BE), where breath tests can complement endoscopic screening; (2) endoluminal diseases associated with autoinflammation and dysbiosis, such as inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and coeliac disease, which currently rely on biopsy and symptom-based diagnosis; (3) chronic liver diseases like cirrhosis, hepatic encephalopathy, and non-alcoholic fatty liver disease, which lack non-invasive diagnostic tools for disease progression monitoring and prognostic assessment. A literature search was conducted through EMBASE, MEDLINE, and Cochrane databases, leading to an overview of 24 studies. The characteristics of these studies, including analytical platforms, disorder type and stage, group size, and performance evaluation parameters for diagnostic tests are discussed. Furthermore, how VOCs can be utilized as non-invasive diagnostic tools to complement existing gold standards is explored. By refining study designs, sampling procedures, and comparing VOCs in urine and blood, we can gain a deeper understanding of the metabolic pathways underlying VOCs. This will establish breath analysis as an effective non-invasive method for differential diagnosis and disease monitoring.<\/jats:p>","DOI":"10.3390\/biomedicines12081815","type":"journal-article","created":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T09:48:54Z","timestamp":1723196934000},"page":"1815","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prospect and Challenges of Volatile Organic Compound Breath Testing in Non-Cancer Gastrointestinal Disorders"],"prefix":"10.3390","volume":"12","author":[{"given":"Weiyang","family":"Zheng","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5890-7835","authenticated-orcid":false,"given":"Ke","family":"Pang","sequence":"additional","affiliation":[{"name":"Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyang","family":"Min","sequence":"additional","affiliation":[{"name":"Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9430-9874","authenticated-orcid":false,"given":"Dong","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China"},{"name":"Clinical Epidemiology Unit, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1073\/pnas.68.10.2374","article-title":"Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography","volume":"68","author":"Pauling","year":"1971","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_2","unstructured":"Beauchamp, J., Davis, C., and Pleil, J. (2020). Chapter 17\u201413C breath tests. Breathborne Biomarkers and the Human Volatilome, Elsevier. [2nd ed.]."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"034001","DOI":"10.1088\/1752-7163\/abf1d0","article-title":"A literature survey of all volatiles from healthy human breath and bodily fluids: The human volatilome","volume":"15","author":"Flynn","year":"2021","journal-title":"J. Breath. Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1136\/gut.43.2008.S47","article-title":"Urea breath tests in the management of Helicobacter pylori infection","volume":"43","author":"Logan","year":"1998","journal-title":"Gut"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1039\/C3CS60329F","article-title":"Assessment, origin, and implementation of breath volatile cancer markers","volume":"43","author":"Haick","year":"2014","journal-title":"Chem. Soc. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"6399","DOI":"10.1021\/acs.chemrev.6b00698","article-title":"Analysis of Volatile Compounds by Advanced Analytical Techniques and Multivariate Chemometrics","volume":"117","author":"Lubes","year":"2017","journal-title":"Chem. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"012001","DOI":"10.1088\/1752-7163\/acff7d","article-title":"Why have only a handful of breath tests made the transition from R&D to clinical practice?","volume":"18","author":"Modak","year":"2024","journal-title":"J. Breath Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: A revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann. Intern. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1136\/gutjnl-2019-320273","article-title":"Detection of Barrett\u2019s oesophagus through exhaled breath using an electronic nose device","volume":"69","author":"Peters","year":"2020","journal-title":"Gut"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1053\/j.gastro.2016.11.001","article-title":"Breath Testing for Barrett\u2019s Esophagus Using Exhaled Volatile Organic Compound Profiling with an Electronic Nose Device","volume":"152","author":"Chan","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"037109","DOI":"10.1088\/1752-7155\/8\/3\/037109","article-title":"Exhaled breath concentrations of acetic acid vapour in gastro-esophageal reflux disease","volume":"8","author":"Dryahina","year":"2014","journal-title":"J. Breath. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1007\/s00216-023-04748-x","article-title":"Application of untargeted volatile profiling in inflammatory bowel disease research","volume":"415","author":"Campillo","year":"2023","journal-title":"Anal. Bioanal. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/apt.14004","article-title":"The potential of volatile organic compounds for the detection of active disease in patients with ulcerative colitis","volume":"45","author":"Smolinska","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"016002","DOI":"10.1088\/1752-7163\/aa8468","article-title":"Pentane and other volatile organic compounds, including carboxylic acids, in the exhaled breath of patients with Crohn\u2019s disease and ulcerative colitis","volume":"12","author":"Dryahina","year":"2017","journal-title":"J. Breath. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.dld.2015.10.013","article-title":"Non-invasive exhaled volatile organic biomarker analysis to detect inflammatory bowel disease (IBD)","volume":"48","author":"Arasaradnam","year":"2016","journal-title":"Dig. Liver Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e201","DOI":"10.1038\/ctg.2016.57","article-title":"A Distinct colon-derived breath metabolome is associated with inflammatory bowel disease, but not its complications","volume":"7","author":"Rieder","year":"2016","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/apt.13654","article-title":"Volatile organic compounds in breath as markers for irritable bowel syndrome: A metabolomic approach","volume":"44","author":"Baranska","year":"2016","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Van Malderen, K., Hanning, N., Lambrechts, H., Haverhals, T., Van Marcke, S., Ceuleers, H., De Man, J.G., De Winter, B.Y., Lamote, K., and De Schepper, H.U. (2022). Volatile organic compound profiling as a potential biomarker in irritable bowel syndrome: A feasibility study. Front. Med., 9.","DOI":"10.3389\/fmed.2022.960000"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s11306-014-0650-1","article-title":"Application of gas chromatography mass spectrometry (GC-MS) in conjunction with multivariate classification for the diagnosis of gastrointestinal diseases","volume":"10","author":"Cauchi","year":"2014","journal-title":"Metabolomics"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"S540","DOI":"10.14309\/00000434-201410002-01827","article-title":"Analysis of Exhaled Volatile Organic Compounds Reveals New Biomarkers for Irritable Bowel Syndrome: ACG Fellow Award: 1827","volume":"109","author":"Patel","year":"2014","journal-title":"Off. J. Am. Coll. Gastroenterol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e00239","DOI":"10.14309\/ctg.0000000000000239","article-title":"Breath Biopsy Assessment of Liver Disease Using an Exogenous Volatile Organic Compound-Toward Improved Detection of Liver Impairment","volume":"11","author":"Ferrandino","year":"2020","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/liv.13214","article-title":"Breath-print analysis by e-nose may refine risk stratification for adverse outcomes in cirrhotic patients","volume":"37","author":"Pennazza","year":"2017","journal-title":"Liver Int."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"De Vincentis, A., Pennazza, G., Santonico, M., Vespasiani-Gentilucci, U., Galati, G., Gallo, P., Vernile, C., Pedone, C., Antonelli Incalzi, R., and Picardi, A. (2016). Breath-print analysis by e-nose for classifying and monitoring chronic liver disease: A proof-of-concept study. Sci. Rep., 6.","DOI":"10.1038\/srep25337"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Pijls, K.E., Smolinska, A., Jonkers, D.M., Dallinga, J.W., Masclee, A.A., Koek, G.H., and van Schooten, F.J. (2016). A profile of volatile organic compounds in exhaled air as a potential non-invasive biomarker for liver cirrhosis. Sci. Rep., 6.","DOI":"10.1038\/srep19903"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1038\/ctg.2015.40","article-title":"Isoprene in the exhaled breath is a novel biomarker for advanced fibrosis in patients with chronic liver disease: A pilot study","volume":"6","author":"Alkhouri","year":"2015","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.ebiom.2015.07.027","article-title":"Volatile Biomarkers in Breath Associated with Liver Cirrhosis\u2014Comparisons of Pre- and Post-liver Transplant Breath Samples","volume":"2","author":"Holt","year":"2015","journal-title":"EBioMedicine"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.cgh.2013.08.048","article-title":"The breathprints in patients with liver disease identify novel breath biomarkers in alcoholic hepatitis","volume":"12","author":"Hanouneh","year":"2014","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Morisco, F., Aprea, E., Lembo, V., Fogliano, V., Vitaglione, P., Mazzone, G., Cappellin, L., Gasperi, F., Masone, S., and De Palma, G.D. (2013). Rapid \u201cBreath-Print\u201d of Liver Cirrhosis by Proton Transfer Reaction Time-of-Flight Mass Spectrometry. A Pilot Study. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0059658"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jchromb.2012.07.025","article-title":"Breath biomarkers of liver cirrhosis","volume":"905","author":"Dadamio","year":"2012","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Posudin, Y. (2014). Methods of Analysis of Volatile Organic Compounds. Methods of Measuring Environmental Parameters, Wiley.","DOI":"10.1002\/9781118914236"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1080\/05704928.2022.2085735","article-title":"An overview of methodologies for the determination of volatile organic compounds in indoor air","volume":"57","author":"Vera","year":"2022","journal-title":"Appl. Spectrosc. Rev."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1021\/cr800364q","article-title":"Proton-Transfer Reaction Mass Spectrometry","volume":"109","author":"Blake","year":"2009","journal-title":"Chem. Rev."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"10803","DOI":"10.1021\/acs.chemrev.9b00005","article-title":"On-Line Analysis of Exhaled Breath","volume":"119","author":"Bruderer","year":"2019","journal-title":"Chem. Rev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1007\/s13361-019-02288-2","article-title":"Ion Mobility Spectrometry: Fundamental Concepts, Instrumentation, Applications, and the Road Ahead","volume":"30","author":"Dodds","year":"2019","journal-title":"J. Am. Soc. Mass. Spectrom."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"7047","DOI":"10.1021\/acsnano.6b03127","article-title":"Silicon Nanowire Sensors Enable Diagnosis of Patients via Exhaled Breath","volume":"10","author":"Shehada","year":"2016","journal-title":"ACS Nano"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1021\/acsnano.6b04930","article-title":"Diagnosis and Classification of 17 Diseases from 1404 Subjects via Pattern Analysis of Exhaled Molecules","volume":"11","author":"Nakhleh","year":"2017","journal-title":"ACS Nano"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/apt.15622","article-title":"Volatile organic compounds in breath can serve as a non-invasive diagnostic biomarker for the detection of advanced adenomas and colorectal cancer","volume":"51","author":"Jansen","year":"2020","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Hanevelt, J., Schoenaker, I.J.H., Brohet, R.M., Schrauwen, R.W.M., Baas, F.J.N., Tanis, P.J., van Westreenen, H.L., and de Vos tot Nederveen Cappel, W.H. (2023). Alteration of the Exhaled Volatile Organic Compound Pattern in Colorectal Cancer Patients after Intentional Curative Surgery\u2014A Prospective Pilot Study. Cancers, 15.","DOI":"10.3390\/cancers15194785"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Po\u013caka, I., Me\u017emale, L., Anarkulova, L., Kononova, E., Vilkoite, I., Veliks, V., \u013be\u0161\u010dinska, A.M., Ston\u0101ns, I., P\u010dolkins, A., and Tolmanis, I. (2023). The Detection of Colorectal Cancer through Machine Learning-Based Breath Sensor Analysis. Diagnostics, 13.","DOI":"10.3390\/diagnostics13213355"},{"key":"ref_40","first-page":"78","article-title":"Food ingestion influence on Sniffphone E-Nose Device breath profile","volume":"23","author":"Vasiljevs","year":"2018","journal-title":"Helicobacter"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/j.ejso.2020.07.028","article-title":"Feasibility of volatile organic compound in breath analysis in the follow-up of colorectal cancer: A pilot study","volume":"46","author":"Steenhuis","year":"2020","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e2219372","DOI":"10.1001\/jamanetworkopen.2022.19372","article-title":"Diagnostic Performance of Electronic Noses in Cancer Diagnoses Using Exhaled Breath: A Systematic Review and Meta-analysis","volume":"5","author":"Scheepers","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1056\/NEJMoa1103042","article-title":"Incidence of adenocarcinoma among patients with Barrett\u2019s esophagus","volume":"365","author":"Pedersen","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1136\/gutjnl-2012-304269","article-title":"Update on the epidemiology of gastro-oesophageal reflux disease: A systematic review","volume":"63","author":"Sweet","year":"2014","journal-title":"Gut"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/j.cgh.2015.07.050","article-title":"Prevalence of Barrett\u2019s Esophagus in Asian Countries: A Systematic Review and Meta-analysis","volume":"13","author":"Shiota","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1016\/j.cgh.2022.06.003","article-title":"AGA Clinical Practice Update on New Technology and Innovation for Surveillance and Screening in Barrett\u2019s Esophagus: Expert Review","volume":"20","author":"Muthusamy","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.gie.2019.05.012","article-title":"ASGE guideline on screening and surveillance of Barrett\u2019s esophagus","volume":"90","author":"Qumseya","year":"2019","journal-title":"Gastrointest. Endosc."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/s-0042-122140","article-title":"Endoscopic management of Barrett\u2019s esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement","volume":"49","author":"Weusten","year":"2017","journal-title":"Endoscopy"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.gie.2020.06.032","article-title":"Prevalence of Barrett\u2019s esophagus and performance of societal screening guidelines in an unreferred primary care population of U.S. veterans","volume":"93","author":"Nguyen","year":"2021","journal-title":"Gastrointest. Endosc."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s10620-018-5336-5","article-title":"Missed Opportunities for Screening and Surveillance of Barrett\u2019s Esophagus in Veterans with Esophageal Adenocarcinoma","volume":"64","author":"Hammad","year":"2019","journal-title":"Dig. Dis. Sci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1016\/j.cgh.2021.04.032","article-title":"Magnitude and Time-Trend Analysis of Postendoscopy Esophageal Adenocarcinoma: A Systematic Review and Meta-analysis","volume":"20","author":"Sawas","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.cgh.2021.02.005","article-title":"Characterization of Prevalent, Post-Endoscopy, and Incident Esophageal Cancer in the United States: A Large Retrospective Cohort Study","volume":"20","author":"Vajravelu","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S0140-6736(09)60254-3","article-title":"Coeliac disease","volume":"373","author":"Corazza","year":"2009","journal-title":"Lancet"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"6036","DOI":"10.3748\/wjg.v18.i42.6036","article-title":"Celiac disease: Prevalence, diagnosis, pathogenesis and treatment","volume":"18","author":"Gujral","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.maturitas.2012.08.005","article-title":"Celiac disease and selected long-term health issues","volume":"73","author":"Freeman","year":"2012","journal-title":"Maturitas"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/s41575-021-00511-8","article-title":"Society for the Study of Celiac Disease position statement on gaps and opportunities in coeliac disease","volume":"18","author":"Silvester","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"037104","DOI":"10.1088\/1752-7155\/7\/3\/037104","article-title":"Profile of volatile organic compounds in exhaled breath changes as a result of gluten-free diet","volume":"7","author":"Baranska","year":"2013","journal-title":"J. Breath. Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jchromb.2014.02.015","article-title":"Application of PTR-TOF-MS to investigate metabolites in exhaled breath of patients affected by coeliac disease under gluten free diet","volume":"966","author":"Aprea","year":"2014","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1053\/j.gastro.2020.04.014","article-title":"Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study","volume":"160","author":"Sperber","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"17","DOI":"10.14309\/ajg.0000000000001036","article-title":"ACG Clinical Guideline: Management of Irritable Bowel Syndrome","volume":"116","author":"Lacy","year":"2021","journal-title":"Am. J. Gastroenterol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e14536","DOI":"10.1111\/nmo.14536","article-title":"Volatile organic compounds as potential biomarkers of irritable bowel syndrome: A systematic review","volume":"35","author":"Zhang","year":"2023","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1159\/000531504","article-title":"Breath Testing in the Surgical Setting: Applications, Challenges, and Future Perspectives","volume":"64","author":"Walsh","year":"2023","journal-title":"Eur. Surg. Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"117692","DOI":"10.1016\/j.cca.2023.117692","article-title":"Breath biomarkers in Non-Carcinogenic diseases","volume":"552","author":"Moura","year":"2024","journal-title":"Clin. Chim. Acta"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Van Malderen, K., De Winter, B.Y., De Man, J.G., De Schepper, H.U., and Lamote, K. (2020). Volatomics in inflammatory bowel disease and irritable bowel syndrome. EBioMedicine, 54.","DOI":"10.1016\/j.ebiom.2020.102725"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/hep.20554","article-title":"Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease","volume":"41","author":"Weston","year":"2005","journal-title":"Hepatology"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"American Association for the Study of Liver Diseases (2014). Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases. J. Hepatol., 61, 642\u2013659.","DOI":"10.1016\/j.jhep.2014.05.042"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"7312","DOI":"10.3748\/wjg.v20.i23.7312","article-title":"Pathogenesis of liver cirrhosis","volume":"20","author":"Zhou","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Mokdad, A.A., Lopez, A.D., Shahraz, S., Lozano, R., Mokdad, A.H., Stanaway, J., Murray, C.J., and Naghavi, M. (2014). Liver cirrhosis mortality in 187 countries between 1980 and 2010: A systematic analysis. BMC Med., 12.","DOI":"10.1186\/s12916-014-0145-y"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","article-title":"Liver cirrhosis","volume":"398","author":"Krag","year":"2021","journal-title":"Lancet"},{"key":"ref_70","first-page":"1","article-title":"Surgery and portal hypertension","volume":"1","author":"Child","year":"1964","journal-title":"Major. Probl. Clin. Surg."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/bjs.1800600817","article-title":"Transection of the oesophagus for bleeding oesophageal varices","volume":"60","author":"Pugh","year":"1973","journal-title":"Br. J. Surg."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jhep.2004.06.005","article-title":"Prognostic models including the Child-Pugh, MELD and Mayo risk scores--where are we and where should we go?","volume":"41","author":"Christensen","year":"2004","journal-title":"J. Hepatol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1053\/he.2000.5852","article-title":"A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts","volume":"31","author":"Malinchoc","year":"2000","journal-title":"Hepatology"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1056\/NEJMra1600561","article-title":"Hepatic Encephalopathy","volume":"375","author":"Wijdicks","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1007\/s11306-013-0510-4","article-title":"Breath volatile analysis from patients diagnosed with harmful drinking, cirrhosis and hepatic encephalopathy: A pilot study","volume":"9","author":"Khalid","year":"2013","journal-title":"Metabolomics"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"016012","DOI":"10.1088\/1752-7155\/10\/1\/016012","article-title":"Breathomics\u2014Exhaled volatile organic compound analysis to detect hepatic encephalopathy: A pilot study","volume":"10","author":"Arasaradnam","year":"2016","journal-title":"J. Breath Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"046010","DOI":"10.1088\/1752-7155\/10\/4\/046010","article-title":"Limonene in exhaled breath is elevated in hepatic encephalopathy","volume":"10","author":"Holt","year":"2016","journal-title":"J. Breath Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.surfcoat.2019.02.049","article-title":"A semi-packed micro GC column for separation of the NAFLD exhaled breath VOCs","volume":"363","author":"Han","year":"2019","journal-title":"Surf. Coat. Technol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jhep.2012.10.030","article-title":"Non-alcoholic steatohepatitis: A non-invasive diagnosis by analysis of exhaled breath","volume":"58","author":"Verdam","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/10408363.2022.2038075","article-title":"Breathing new life into clinical testing and diagnostics: Perspectives on volatile biomarkers from breath","volume":"59","author":"Haworth","year":"2022","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"034001","DOI":"10.1088\/1752-7163\/ab7f9d","article-title":"A mechanistic study and review of volatile products from peroxidation of unsaturated fatty acids: An aid to understanding the origins of volatile organic compounds from the human body","volume":"14","author":"Ratcliffe","year":"2020","journal-title":"J. Breath. Res."},{"key":"ref_83","first-page":"257","article-title":"Methane and hydrogen production by human intestinal anaerobic bacteria","volume":"90","author":"McKay","year":"1982","journal-title":"Acta Pathol. Microbiol. Immunol. Scand. B"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"032001","DOI":"10.1088\/1752-7163\/ab1789","article-title":"Targeted breath analysis: Exogenous volatile organic compounds (EVOC) as metabolic pathway-specific probes","volume":"13","author":"Gaude","year":"2019","journal-title":"J. Breath. Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"7247802","DOI":"10.1155\/2019\/7247802","article-title":"Volatile organic compounds as biomarkers of gastrointestinal diseases and nutritional status","volume":"2019","author":"Rondanelli","year":"2019","journal-title":"J. Anal. Methods Chem."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Chung, J., Akter, S., Han, S., Shin, Y., Choi, T.G., Kang, I., and Kim, S.S. (2022). Diagnosis by Volatile Organic Compounds in Exhaled Breath in Exhaled Breath from Patients with Gastric and Colorectal Cancers. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24010129"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"van Vorstenbosch, R., Cheng, H.R., Jonkers, D., Penders, J., Schoon, E., Masclee, A., van Schooten, F.J., Smolinska, A., and Mujagic, Z. (2022). Systematic Review: Contribution of the Gut Microbiome to the Volatile Metabolic Fingerprint of Colorectal Neoplasia. Metabolites, 13.","DOI":"10.3390\/metabo13010055"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"E20937","DOI":"10.1097\/MD.0000000000020937","article-title":"Volatile organic compounds analysis as a potential novel screening tool for colorectal cancer: A systematic review and meta-analysis","volume":"99","author":"Zhou","year":"2020","journal-title":"Medicine"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"e182815","DOI":"10.1001\/jamaoncol.2018.2815","article-title":"Accuracy and Methodologic Challenges of Volatile Organic Compound-Based Exhaled Breath Tests for Cancer Diagnosis: A Systematic Review and Meta-analysis","volume":"5","author":"Hanna","year":"2019","journal-title":"JAMA Oncol."},{"key":"ref_90","first-page":"383","article-title":"New Techniques to Screen for Barrett Esophagus","volume":"19","author":"Strauss","year":"2023","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.14309\/ajg.0000000000001336","article-title":"Comparative Cost Effectiveness of Reflux-Based and Reflux-Independent Strategies for Barrett\u2019s Esophagus Screening","volume":"116","author":"Sami","year":"2021","journal-title":"Am. J. Gastroenterol."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Chin, S.T., Romano, A., Doran, S.L.F., and Hanna, G.B. (2018). Cross-platform mass spectrometry annotation in breathomics of oesophageal-gastric cancer. Sci. Rep., 8.","DOI":"10.1038\/s41598-018-22890-w"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/12\/8\/1815\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:32:55Z","timestamp":1760110375000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/12\/8\/1815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,9]]},"references-count":92,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["biomedicines12081815"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines12081815","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,9]]}}}